Literature DB >> 8180904

A proposal for classification of neurocysticercosis.

A Carpio1, M Placencia, F Santillán, A Escobar.   

Abstract

The complicated pathophysiological and immunological changes in the central nervous system of patients with neurocysticercosis produce a variety of signs and symptoms, which complicate the clinical and surgical management of this disease. A complete and objective classification is needed, to improve the medical approach as a whole. We studied 336 patients, in whom we classified neurocysticerosis according to criteria of viability and location of the parasite in the CNS: active form (37.2%) when the cysticercus is alive, transitional form (32.8%) when it is in the degenerative phase, and inactive form (30%) when the parasite is dead. This classification establishes the correlation between the different forms of neurocysticerosis and its clinical manifestations, and can be used for planning therapeutic strategies.

Entities:  

Mesh:

Year:  1994        PMID: 8180904     DOI: 10.1017/s0317167100048757

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  24 in total

1.  Back to the ring: knocking-out headache.

Authors:  Marco Tironi; Lucio Tremolizzo; Giovanni Stefanoni; Monica Airoldi; Eleonora Motta; Mirko Patassini; Francesco Canonico; Carlo Ferrarese; Ildebrando Appollonio
Journal:  Neurol Sci       Date:  2011-11-29       Impact factor: 3.307

2.  A pain in the…ventricle.

Authors:  Minh-Chi Tran; Sanjiv M Baxi; Bruno P Soares
Journal:  J Gen Intern Med       Date:  2013-10-11       Impact factor: 5.128

3.  Microsurgical Treatment of Epilepsy with Parenchymal Neurocysticercosis.

Authors:  Yu-Tang Tan; Suo-Jun Zhang; Kai Shu; Ting Lei; Hong-Quan Niu
Journal:  Curr Med Sci       Date:  2019-12-16

4.  Prevalence of neurocysticercosis among people with epilepsy in rural areas of Burkina Faso.

Authors:  Athanase Millogo; Pascal Nitiéma; Hélène Carabin; Marie Paule Boncoeur-Martel; Vedantam Rajshekhar; Zékiba Tarnagda; Nicolas Praet; Pierre Dorny; Linda Cowan; Rasmané Ganaba; Sennen Hounton; Pierre-Marie Preux; Rabiou Cissé
Journal:  Epilepsia       Date:  2012-11-13       Impact factor: 5.864

5.  Exploring the complex associations over time among albendazole treatment, cyst evolution, and seizure outcomes in neurocysticercosis.

Authors:  Arturo Carpio; Mindy Chang; Hongbin Zhang; Matthew L Romo; Alex Jaramillo; W Allen Hauser; Elizabeth A Kelvin
Journal:  Epilepsia       Date:  2019-07-29       Impact factor: 5.864

6.  Neurocysticercosis: an update.

Authors:  Christina M Coyle
Journal:  Curr Infect Dis Rep       Date:  2014-11       Impact factor: 3.725

7.  A Stratified Analysis of Clinical Manifestations and Different Diagnostic Methods of Neurocysticercosis-Suspected Tamilian Population Residing in and Around Puducherry.

Authors:  Piriyatharisini Thamilselvan; Krishna Raja Muthuraman; Sheeba Arockiamary Thasan; Gayathri Kasinathan; Jharna Mandal; Subhash Chandra Parija
Journal:  J Clin Diagn Res       Date:  2017-05-01

Review 8.  Neurocysticercosis.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  1998-06       Impact factor: 2.401

9.  Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study.

Authors:  Theodore E Nash; E Javier Pretell; Andres G Lescano; Javier A Bustos; Robert H Gilman; Armando E Gonzalez; Héctor H Garcia
Journal:  Lancet Neurol       Date:  2008-11-03       Impact factor: 44.182

Review 10.  A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy.

Authors:  Patrick C Ndimubanzi; Hélène Carabin; Christine M Budke; Hai Nguyen; Ying-Jun Qian; Elizabeth Rainwater; Mary Dickey; Stephanie Reynolds; Julie A Stoner
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.